Silvia Contino
Overview
Explore the profile of Silvia Contino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gottardo A, Gristina V, Perez A, Di Giovanni E, Contino S, Barraco N, et al.
J Liq Biopsy
. 2025 Mar;
3:100136.
PMID: 40026563
Due to their interactions with the neoplasm, platelets undergo various proteomic and transcriptomic modifications, resulting in the development of what is known as the "Tumor-Educated Platelets (TEPs) phenotype". Consequently, in...
2.
Incorvaia L, Bazan Russo T, Gristina V, Perez A, Brando C, Mujacic C, et al.
NPJ Precis Oncol
. 2024 Sep;
8(1):190.
PMID: 39237751
Homologous recombination (HR) and mismatch repair (MMR) defects are driver mutational imprints and actionable biomarkers in DNA repair-defective tumors. Although usually thought as mutually exclusive pathways, recent preclinical and clinical...
3.
Bazan Russo T, Mujacic C, Di Giovanni E, Vitale M, Ferrante Bannera C, Randazzo U, et al.
Cancer Gene Ther
. 2024 Aug;
31(11):1619-1631.
PMID: 39122831
The most remarkable finding in synthetic lethality (SL) is the hypersensitivity to PARP inhibitors (PARPis) of the tumors harboring defects in genes involved in homologous repair (HR) such as BRCA1/2....
4.
Gottardo A, Bazan Russo T, Perez A, Bono M, Di Giovanni E, Di Marco E, et al.
Cytopathology
. 2024 Jun;
35(6):664-670.
PMID: 38822635
The transformative role of artificial intelligence (AI) and multiomics could enhance the diagnostic and prognostic capabilities of liquid biopsy (LB) for lung cancer (LC). Despite advances, the transition from tissue...
5.
Iannuccelli M, Vitriolo A, Licata L, Lo Surdo P, Contino S, Cheroni C, et al.
Mol Psychiatry
. 2024 Jan;
29(1):197.
PMID: 38267621
No abstract available.
6.
Iannuccelli M, Vitriolo A, Licata L, Lo Surdo P, Contino S, Cheroni C, et al.
Mol Psychiatry
. 2023 Dec;
29(1):186-196.
PMID: 38102483
Autism spectrum disorder (ASD) comprises a large group of neurodevelopmental conditions featuring, over a wide range of severity and combinations, a core set of manifestations (restricted sociality, stereotyped behavior and...
7.
Fanale D, Corsini L, Bono M, Randazzo U, Barraco N, Brando C, et al.
Crit Rev Oncol Hematol
. 2023 Nov;
193:104220.
PMID: 38036154
Specific tumor-derived extracellular vesicles, called exosomes, are considered as potential key players in cross-talk between immune system and tumor microenvironment in several solid tumors. Different studies highlighted the clinical relevance...
8.
Incorvaia L, Perez A, Marchetti C, Brando C, Gristina V, Cancelliere D, et al.
Cancer Treat Rev
. 2023 Nov;
121:102650.
PMID: 37939446
Breast cancer susceptibility gene 1 (BRCA1) and breast cancer susceptibility gene 2 (BRCA2) deleterious variants were the first and, still today, the main biomarkers of poly(ADP)ribose polymerase (PARP)-inhibitors (PARPis) benefit....
9.
Fanale D, Corsini L, Pedone E, Randazzo U, Fiorino A, Di Piazza M, et al.
Crit Rev Oncol Hematol
. 2023 Aug;
190:104086.
PMID: 37536445
Germline BRCA1/2 alterations in the Homologous Recombination (HR) pathway are considered as main susceptibility biomarkers to Hereditary Breast and Ovarian Cancers (HBOC). The modern molecular biology technologies allowed to characterize...
10.
Dimino A, Brando C, Algeri L, Gristina V, Pedone E, Peri M, et al.
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612211
Gastrointestinal Stromal Tumors (GISTs) represent a paradigmatic model of oncogene addiction. Despite the well-known impact of the mutational status on clinical outcomes, we need to expand our knowledge to other...